Recent Finacing
Recent Raise
GenEdit develops non-viral polymer nanoparticle platforms (NanoGalaxy/HNPs) for tissue-selective delivery of DNA, RNA, and CRISPR RNPs via IV or intrathecal administration for internal and partner therapeutic programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at GenEdit.
